HIV/AIDS
HIV infection is a chronic, progressive disease, caused by viral replication within CD4 positive cells that eventually destroys the cells. Initially the immune system is capable of producing new cells to replace those that are destroyed -transplantation. The early stages of HIV infection T-cell levels generally remain near normal. This period of the disease is known as the dormant stage since few symptoms are apparent. Based on clinical data the average time between infection and the development of full-blown AIDS is over 10 years. With time the CD4 count declines as T-cells are destroyed more rapidly than the immune system can produce them, leading to serious impairment of immune function. A dramatic increase in susceptibility to opportunistic infections has been observed with an absolute CD4 count of 200 cells/mm3 or fewer. Overall survival among patients who have an AIDS-defining diagnosis (over 30 conditions have been identified) and fewer than 200 CD4 cells is to the order of 3 years, but with wide variation.
For most patients, the course of AIDS can be characterized as repeated acute episodes of illness with a background of slowly declining health and function. Sudden death is rare. Most patients become bed-bound for weeks to months before death, requiring increasing support including home infusion of antibiotics, nursing care, nutritional supplementation, and in many cases treatment for anxiety and depression.
AIDS has become the most devastating infectious disease humankind has ever faced. Since the epidemic began, more than 60 million people have been infected with the virus. Worldwide, it is the fourth-biggest killer. At the end of 2001, an estimated 40 million people globally were living with HIV.
Worldwide Prevalence of HIV
Recently there has been a rise in the incidence of HIV infection in developed nations. Advances in treatment and care in these countries are not being consistently matched with enough progress on the prevention front. New evidence of rising HIV infection rates in North America, parts of Europe and Australia is emerging. Unsafe sex, reflected in outbreaks of sexually transmitted infections, and widespread injection drug use are propelling these epidemics.
Advances in medication have increased the life span of AIDS patients, but the impact has been modest. Experts believe current treatments only extend life by 1.8 years on average. The following multifactorial etiologies contribute to the eventual decline in therapeutic efficacy:
- HIV is prone to mutations that produce resistance to reverse transcriptase and protease inhibitors. Once resistance emerges to one drug, these strains may also be resistant to most, if not all, of the drugs in the same chemical or functional group
- Patient compliance with existing HIV treatment regimens is a significant issue that mitigates therapeutic success. In an effort to overcome resistance, physicians have begun prescribing reverse transcriptase and protease inhibitors in various combinations. The demands of these complex drug dosing regimens are often too great for long-term patient adherence
- Clinical studies indicate that a significant number of HIV positive patients discontinue therapy soon after they begin treatment because they cannot tolerate the toxic side effects. These include gastrointestinal disorders, peripheral neuropathy, kidney stones, and diabetes-like symptoms
HIV and AIDS: Understanding the Difference
HIV and AIDS are not the same thing. HIV is the virus, while AIDS is a condition that can develop during advanced HIV infection when the immune system has been significantly damaged.
With effective modern treatment, many people with HIV do not progress to AIDS. Treatment can suppress HIV replication, preserve immune function, and substantially reduce the risk of HIV-related complications.
HIV Treatment and Long-Term Management
Antiretroviral therapy (ART) is used to control HIV. These medicines work by targeting different stages of the HIV life cycle and reducing the amount of virus in the body.
When treatment effectively suppresses HIV, the immune system can be protected and the risk of developing AIDS-related complications can be greatly reduced.
Maintaining consistent treatment and monitoring are important components of long-term HIV management.
Understanding the Global Impact of HIV
HIV has had a major impact on communities around the world since the beginning of the epidemic. Millions of people have been affected, making HIV one of the most significant infectious diseases in modern history.
Advances in testing, prevention, antiretroviral therapy, and public awareness have significantly changed the outlook for people living with HIV. However, access to testing and treatment remains an important global issue.
Frequently Asked Questions About HIV/AIDS
Nexavir has been studied for properties associated with viral activity, inflammation, and immune-system responses. Its potential relevance to HIV/AIDS has been an area of research interest.
Nexavir is formulated using processed porcine liver extract. Information about its formulation and ingredients can be explored on the Nexavir product page.
Research involving Nexavir has included investigations into areas such as viral activity, inflammatory pathways, and immune-system responses. Some studies have examined its use in contexts associated with HIV, contributing to ongoing scientific interest in its potential applications and biological effects.
HIV primarily affects CD4 T cells, which play an important role in immune-system function. As HIV progresses without effective management, the immune system can become increasingly weakened.
HIV is a virus that affects the immune system, while AIDS refers to the most advanced stage of HIV infection, when significant immune-system damage has occurred.
You can explore the Nexavir product information and Research & Uses sections to learn more about its formulation, background, and research related to viral conditions.